BridgeBio Oncology Therapeutics (BBOT) Selling, General & Administrative (2024 - 2026)
BridgeBio Oncology Therapeutics' Selling, General & Administrative came in at $10.96 million for Q2 2026, up 312.9% from $2.66 million a year earlier and up 71.9% from the prior quarter.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Selling, General & Administrative (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BridgeBio Oncology Therapeutics reported Selling, General & Administrative of $36.8 million, up 297.0% year-over-year; for FY2025, it was $24.62 million, up 217.4% from FY2024.
- Going back by year, Selling, General & Administrative was $7.76 million in FY2024 and $41,692 in FY2023.
- The five-year range for quarterly Selling, General & Administrative is $66,701 (Q1 2024) to $14.13 million (Q3 2025).
- Year-over-year, Selling, General & Administrative has increased for four consecutive quarters, with growth averaging 323.0% over the last four quarters.
- Business Quant data shows BBOT's Selling, General & Administrative at $6.38 million (Q1 2026), $5.33 million (Q4 2025) and $14.13 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | BridgeBio Oncology Therapeutics | 328.47 Mn | -1.04 Bn | - | 10.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.96 Mn |
| Mar 31, 2026 | 6.38 Mn |
| Dec 31, 2025 | 5.33 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 152,343.00 |
| Mar 31, 2024 | 66,701.00 |
API Access
BridgeBio Oncology Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BBOT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BBOT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BBOT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();